GEORGE VAN BUREN

Concepts (288)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Pancreaticoduodenectomy
12
2022
92
2.930
Why?
Pancreatic Neoplasms
23
2025
685
2.680
Why?
Drainage
9
2021
257
2.110
Why?
Carcinoma, Pancreatic Ductal
13
2025
153
2.070
Why?
Pancreatic Fistula
5
2021
29
1.720
Why?
Postoperative Care
4
2019
295
1.410
Why?
Postoperative Complications
11
2021
3062
1.170
Why?
Pancreatectomy
10
2023
137
1.110
Why?
Pancreas
4
2023
217
0.880
Why?
Adenocarcinoma
7
2023
998
0.720
Why?
Pancreatitis
1
2020
130
0.650
Why?
Choristoma
1
2018
49
0.620
Why?
Pancreatic Diseases
1
2018
39
0.620
Why?
Incidental Findings
1
2018
124
0.590
Why?
Spleen
1
2018
280
0.580
Why?
Clinical Protocols
1
2018
235
0.580
Why?
Nutritional Support
1
2017
54
0.530
Why?
Metabolic Diseases
1
2017
129
0.490
Why?
Antineoplastic Combined Chemotherapy Protocols
5
2019
1240
0.480
Why?
Colorectal Neoplasms
7
2009
566
0.470
Why?
Vascular Endothelial Growth Factor A
5
2008
411
0.450
Why?
Gastrointestinal Microbiome
1
2020
694
0.430
Why?
Pancreatitis, Chronic
3
2023
68
0.420
Why?
Liver Neoplasms, Experimental
2
2009
61
0.400
Why?
Receptors, Urokinase Plasminogen Activator
1
2009
22
0.330
Why?
Humans
51
2025
124311
0.330
Why?
Pancreatic Cyst
2
2019
30
0.320
Why?
Neoplasm Transplantation
3
2021
374
0.320
Why?
Neovascularization, Pathologic
2
2008
240
0.310
Why?
ErbB Receptors
2
2019
286
0.300
Why?
Liver Regeneration
1
2008
38
0.300
Why?
Health Status Disparities
2
2025
227
0.300
Why?
Prospective Studies
8
2020
6083
0.300
Why?
Jejunal Diseases
1
2007
15
0.290
Why?
Ileal Neoplasms
1
2007
6
0.290
Why?
Carcinoid Tumor
1
2007
25
0.280
Why?
Neoplasm Recurrence, Local
1
2013
1127
0.280
Why?
Cell Proliferation
8
2019
2303
0.260
Why?
Antibodies, Monoclonal
2
2009
1015
0.260
Why?
Aged
17
2025
19456
0.260
Why?
Intestinal Obstruction
1
2007
97
0.260
Why?
Middle Aged
19
2025
26428
0.250
Why?
Male
25
2025
60976
0.250
Why?
Retrospective Studies
11
2022
16223
0.230
Why?
Precancerous Conditions
2
2019
283
0.230
Why?
Tumor Microenvironment
2
2025
549
0.220
Why?
Female
23
2025
66248
0.220
Why?
Nitric Oxide
1
2006
444
0.220
Why?
Anastomosis, Surgical
2
2021
168
0.220
Why?
Mass Spectrometry
2
2021
331
0.210
Why?
RNA, Small Interfering
3
2018
670
0.210
Why?
Receptors, Vascular Endothelial Growth Factor
3
2008
93
0.210
Why?
Cell Line, Tumor
9
2019
3342
0.210
Why?
Quality of Life
3
2023
1950
0.200
Why?
Laparoscopy
2
2020
489
0.190
Why?
Amylases
2
2019
26
0.190
Why?
Cancer Vaccines
1
2023
177
0.190
Why?
Margins of Excision
1
2021
51
0.180
Why?
Biomedical Technology
1
2021
36
0.180
Why?
Heterografts
1
2021
177
0.180
Why?
Drug Resistance, Neoplasm
3
2019
723
0.180
Why?
Liver
1
2008
1760
0.180
Why?
Antineoplastic Agents
4
2018
1674
0.180
Why?
Follow-Up Studies
5
2019
5107
0.170
Why?
Pleural Neoplasms
1
2020
48
0.170
Why?
Mice, Nude
3
2018
710
0.170
Why?
Immunotherapy
2
2023
662
0.170
Why?
Cystadenoma, Serous
1
2019
5
0.170
Why?
Neoplasms
2
2021
2794
0.160
Why?
Device Removal
2
2018
223
0.160
Why?
Cell Movement
6
2018
835
0.160
Why?
Transforming Growth Factor alpha
1
2019
27
0.160
Why?
Tumor Suppressor Protein p53
2
2025
719
0.160
Why?
Killer Cells, Natural
1
2021
324
0.160
Why?
HSP70 Heat-Shock Proteins
1
2019
68
0.160
Why?
Preservation, Biological
1
2018
9
0.160
Why?
Positron-Emission Tomography
1
2020
298
0.160
Why?
RNAi Therapeutics
1
2018
17
0.160
Why?
GPI-Linked Proteins
1
2019
98
0.150
Why?
Semaphorins
2
2016
31
0.150
Why?
Pathologists
1
2018
29
0.150
Why?
Diagnosis, Differential
2
2018
1887
0.150
Why?
Neuropilin-2
2
2008
9
0.150
Why?
Radiologists
1
2018
44
0.150
Why?
Nutritional Status
2
2019
312
0.150
Why?
T-Lymphocytes, Cytotoxic
1
2021
501
0.150
Why?
Biological Specimen Banks
1
2018
51
0.150
Why?
Xenograft Model Antitumor Assays
4
2021
887
0.150
Why?
Mesenteric Veins
1
2018
15
0.150
Why?
Clinical Enzyme Tests
1
2018
14
0.150
Why?
Specimen Handling
1
2018
140
0.150
Why?
Random Allocation
2
2009
436
0.150
Why?
Organoplatinum Compounds
2
2008
29
0.140
Why?
Neoplasm Staging
3
2020
1218
0.140
Why?
Adult
8
2020
29357
0.140
Why?
Guidelines as Topic
1
2018
198
0.140
Why?
Non-Randomized Controlled Trials as Topic
1
2017
13
0.140
Why?
Evidence-Based Practice
1
2018
114
0.130
Why?
Combined Modality Therapy
3
2017
1245
0.130
Why?
Nuclear Receptor Coactivator 3
1
2018
348
0.130
Why?
Treatment Outcome
9
2019
12279
0.130
Why?
Time-to-Treatment
1
2018
187
0.130
Why?
Transplantation, Heterologous
3
2021
254
0.130
Why?
Risk Factors
6
2021
10134
0.130
Why?
Venous Thrombosis
1
2018
181
0.130
Why?
Duodenal Neoplasms
1
2016
21
0.130
Why?
Mice
9
2023
17740
0.130
Why?
Proto-Oncogene Proteins c-ets
1
2016
60
0.120
Why?
Randomized Controlled Trials as Topic
2
2018
1099
0.120
Why?
Animals
12
2023
34154
0.120
Why?
Databases, Factual
2
2018
1174
0.120
Why?
Lymph Nodes
1
2017
376
0.120
Why?
Incidence
4
2019
3085
0.120
Why?
Evidence-Based Medicine
1
2019
627
0.120
Why?
Wnt Signaling Pathway
1
2016
196
0.120
Why?
Risk Assessment
2
2021
3371
0.120
Why?
Patient Care Team
1
2018
545
0.120
Why?
Surgeons
1
2018
255
0.110
Why?
Early Termination of Clinical Trials
1
2014
16
0.110
Why?
Malnutrition
1
2017
203
0.110
Why?
Neoplasm Invasiveness
5
2018
606
0.110
Why?
Tomography, X-Ray Computed
2
2018
2087
0.110
Why?
Bile Duct Diseases
1
2013
17
0.110
Why?
Bile
1
2013
46
0.110
Why?
Bevacizumab
1
2013
63
0.110
Why?
Deoxycytidine
1
2013
76
0.110
Why?
DNA Methylation
1
2019
1000
0.100
Why?
Radiotherapy Dosage
1
2013
186
0.100
Why?
Diabetes Mellitus, Type 1
1
2021
822
0.100
Why?
Medical Oncology
1
2014
215
0.100
Why?
Remission Induction
1
2013
301
0.100
Why?
Practice Patterns, Physicians'
1
2019
719
0.100
Why?
Length of Stay
2
2018
1306
0.100
Why?
Erythrocyte Transfusion
1
2013
128
0.100
Why?
Gastroenterology
1
2014
191
0.090
Why?
Biomarkers
2
2018
2976
0.090
Why?
Preoperative Care
1
2013
349
0.090
Why?
Surgical Wound Infection
1
2013
265
0.090
Why?
Mutation
3
2025
5806
0.090
Why?
Healthcare Disparities
1
2015
428
0.090
Why?
Medically Uninsured
1
2010
73
0.080
Why?
Prognosis
2
2023
4554
0.080
Why?
Antibodies, Monoclonal, Humanized
1
2013
504
0.080
Why?
Liver Neoplasms
2
2010
1319
0.080
Why?
Gene Expression Regulation, Neoplastic
3
2018
1900
0.080
Why?
Inhibitor of Differentiation Protein 2
1
2008
3
0.080
Why?
Receptor, IGF Type 1
1
2009
93
0.080
Why?
Survival Rate
1
2013
2020
0.080
Why?
Injections, Intraperitoneal
1
2008
73
0.080
Why?
Disease-Free Survival
2
2023
860
0.070
Why?
DNA-Binding Proteins
1
2016
2055
0.070
Why?
Hepatectomy
1
2008
110
0.070
Why?
Jejunum
1
2007
129
0.070
Why?
Gastrointestinal Neoplasms
1
2007
79
0.070
Why?
Chemotherapy, Adjuvant
2
2018
355
0.070
Why?
Neoplastic Stem Cells
1
2009
300
0.070
Why?
Constriction, Pathologic
1
2007
244
0.070
Why?
Signal Transduction
6
2019
4534
0.070
Why?
Serotonin
1
2007
232
0.060
Why?
Nitric Oxide Synthase
1
2006
186
0.060
Why?
Mesoderm
1
2006
113
0.060
Why?
Mice, Inbred BALB C
1
2008
1006
0.060
Why?
Severity of Illness Index
1
2014
2895
0.060
Why?
Transcription Factors
1
2016
2607
0.060
Why?
Registries
3
2019
1410
0.060
Why?
Epithelium
1
2006
361
0.060
Why?
Tissue Array Analysis
1
2025
137
0.060
Why?
Chromosome Aberrations
1
2007
621
0.060
Why?
Survival Analysis
2
2018
1482
0.060
Why?
Frozen Sections
1
2023
25
0.060
Why?
Neoadjuvant Therapy
2
2017
326
0.060
Why?
5'-Nucleotidase
1
2023
16
0.050
Why?
Observer Variation
1
2023
302
0.050
Why?
Time Factors
3
2019
6264
0.050
Why?
Adenosine
1
2023
127
0.050
Why?
Cell Survival
2
2019
806
0.050
Why?
Anti-Bacterial Agents
1
2013
2417
0.050
Why?
Common Bile Duct
1
2021
14
0.050
Why?
Carcinoma, Hepatocellular
1
2010
938
0.050
Why?
Parathyroidectomy
1
2021
49
0.050
Why?
Intraoperative Care
1
2021
104
0.050
Why?
Thyroid Gland
1
2021
113
0.040
Why?
Predictive Value of Tests
2
2018
2122
0.040
Why?
Interleukin-15
1
2021
91
0.040
Why?
Statistics as Topic
1
2021
253
0.040
Why?
Bone Morphogenetic Protein 3
1
2019
1
0.040
Why?
Cyst Fluid
1
2019
6
0.040
Why?
Carcinoembryonic Antigen
1
2019
20
0.040
Why?
Immunohistochemistry
3
2008
1686
0.040
Why?
Cetuximab
1
2019
12
0.040
Why?
Adjuvants, Immunologic
1
2021
380
0.040
Why?
Pyrimidinones
1
2019
40
0.040
Why?
Neoplasm Grading
1
2019
266
0.040
Why?
Cohort Studies
2
2018
4729
0.040
Why?
Proto-Oncogene Proteins p21(ras)
1
2019
158
0.040
Why?
T-Box Domain Proteins
1
2019
121
0.040
Why?
Radiotherapy, Adjuvant
1
2018
142
0.040
Why?
Pyridones
1
2019
112
0.040
Why?
Patient Reported Outcome Measures
1
2019
171
0.040
Why?
Tumor Burden
1
2018
229
0.040
Why?
Immunoprecipitation
2
2008
199
0.040
Why?
Apoptosis
3
2009
1790
0.040
Why?
Vascular Patency
1
2018
213
0.040
Why?
Mice, SCID
1
2018
571
0.040
Why?
Tumor Cells, Cultured
1
2019
1064
0.030
Why?
Blood Loss, Surgical
1
2018
152
0.030
Why?
Confidence Intervals
1
2017
279
0.030
Why?
Blood Glucose
1
2021
1129
0.030
Why?
Lymph Node Excision
1
2017
157
0.030
Why?
Cell Cycle
1
2019
615
0.030
Why?
Cell Nucleus
1
2019
677
0.030
Why?
Extracellular Signal-Regulated MAP Kinases
1
2016
143
0.030
Why?
Ampulla of Vater
1
2016
16
0.030
Why?
Lymphatic Metastasis
1
2017
402
0.030
Why?
Carcinogenesis
1
2019
334
0.030
Why?
Insulin
1
2021
1207
0.030
Why?
Polymerase Chain Reaction
1
2019
1583
0.030
Why?
Proteomics
1
2019
488
0.030
Why?
Microsatellite Repeats
1
2016
219
0.030
Why?
MAP Kinase Signaling System
1
2016
314
0.030
Why?
Reoperation
1
2018
830
0.030
Why?
Patient Readmission
1
2018
377
0.030
Why?
Sensitivity and Specificity
1
2019
2029
0.030
Why?
Genomic Instability
1
2016
229
0.030
Why?
Proportional Hazards Models
1
2017
1320
0.030
Why?
Molecular Diagnostic Techniques
1
2014
150
0.030
Why?
Hospital Mortality
1
2018
1020
0.030
Why?
Monitoring, Intraoperative
1
2013
127
0.030
Why?
Biomedical Research
1
2018
518
0.030
Why?
Surveys and Questionnaires
1
2023
3726
0.030
Why?
Reproducibility of Results
1
2019
2870
0.030
Why?
Antibiotic Prophylaxis
1
2013
119
0.020
Why?
Hemoglobins
1
2013
306
0.020
Why?
Molecular Targeted Therapy
1
2014
353
0.020
Why?
Drug Administration Schedule
1
2013
725
0.020
Why?
Precision Medicine
1
2014
313
0.020
Why?
Base Sequence
1
2016
3093
0.020
Why?
Perioperative Care
1
2013
197
0.020
Why?
Early Detection of Cancer
1
2014
356
0.020
Why?
Disease Models, Animal
1
2021
4355
0.020
Why?
Molecular Sequence Data
1
2016
3873
0.020
Why?
Patient Selection
1
2014
688
0.020
Why?
Diabetes Mellitus
1
2018
853
0.020
Why?
Aged, 80 and over
1
2020
6467
0.020
Why?
HT29 Cells
1
2009
45
0.020
Why?
AC133 Antigen
1
2009
35
0.020
Why?
Hyaluronan Receptors
1
2009
66
0.020
Why?
Serrate-Jagged Proteins
1
2008
38
0.020
Why?
Vascular Endothelial Growth Factor B
1
2008
7
0.020
Why?
Vascular Endothelial Growth Factor C
1
2008
9
0.020
Why?
Autoradiography
1
2008
71
0.020
Why?
Placenta Growth Factor
1
2008
11
0.020
Why?
Fluorouracil
1
2009
128
0.020
Why?
Jagged-1 Protein
1
2008
53
0.020
Why?
Pregnancy Proteins
1
2008
13
0.020
Why?
Culture Media, Conditioned
1
2008
79
0.020
Why?
Half-Life
1
2008
156
0.020
Why?
Neuropilin-1
1
2007
15
0.020
Why?
HCT116 Cells
1
2008
55
0.020
Why?
Cell Hypoxia
1
2008
95
0.020
Why?
Vascular Endothelial Growth Factor Receptor-1
1
2008
42
0.020
Why?
Immunoblotting
1
2008
313
0.020
Why?
Kaplan-Meier Estimate
1
2010
1017
0.020
Why?
Calcium-Binding Proteins
1
2008
324
0.020
Why?
Intercellular Signaling Peptides and Proteins
1
2008
280
0.020
Why?
Liposomes
1
2008
169
0.020
Why?
Antigens, CD
1
2009
421
0.020
Why?
Glycoproteins
1
2009
370
0.020
Why?
Spindle Apparatus
1
2006
63
0.020
Why?
Blotting, Western
1
2008
1109
0.020
Why?
Flow Cytometry
1
2008
802
0.020
Why?
Hepatitis C, Chronic
1
2010
324
0.020
Why?
Up-Regulation
1
2008
862
0.020
Why?
Transfection
1
2008
1069
0.020
Why?
Peptides
1
2009
793
0.020
Why?
Cadherins
1
2006
165
0.020
Why?
Carcinoma
1
2008
281
0.020
Why?
Proto-Oncogene Proteins c-akt
1
2008
488
0.020
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2008
1289
0.010
Why?
Neoplasm Metastasis
1
2006
662
0.010
Why?
Transcription, Genetic
1
2008
1701
0.010
Why?
RNA, Messenger
1
2008
2824
0.010
Why?
Disease Progression
1
2008
2038
0.010
Why?
Texas
1
2010
3590
0.010
Why?
Membrane Proteins
1
2008
1530
0.010
Why?
United States
1
2015
10757
0.010
Why?
Phenotype
1
2009
4257
0.010
Why?
Child
1
2018
24514
0.010
Why?
VAN BUREN's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (288)
Explore
_
Co-Authors (34)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_